A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study

Ömer Toprak, Hüseyin Kurt, Yasin Sarı et al. · Kidney & Blood Pressure Research · 2017 · 29.7K citations · Full text

Medicine, Endocrinology, Nutrition +17

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

Andrew S. Levey, Josef Coresh, Kline Bolton et al. · Data Archiving and Networked Services (DANS) · 2002 · 11.7K citations

Medicine, Nephrology, Hemodialysis +13

Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

Michael J. Pencina, Ralph B. D' Agostino, Ralph B. D' Agostino et al. · Statistics in Medicine · 2007 · 6.3K citations · Full text

Medicine, Biostatistics, Cardiology +17

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial

Ami E. Iskandrian, Timothy M. Bateman, Luiz Belardinelli et al. · Journal of Nuclear Cardiology · 2007 · 345 citations

Medicine, Cardiology, Radiology +17

Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging

Manuel D. Cerqueira, Patricia K. Nguyen, Peter Staehr et al. · JACC. Cardiovascular imaging · 2008 · 241 citations

Medicine, Cardiology, Pharmacology +11